Global Metabolomics Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Metabolomics is the quantification and identification of the complete set of metabolites in a biological system. Simply a study of chemical processes involving metabolites is considered as metabolomics. The field of metabolomics study the chemical fingerprints left behind by biological processes. Some healthcare applications of metabolomics include lead compound optimisation, lead compound discovery, efficacy and metabolism of a drug, biomarker identification and providing clarity on the mechanism of action.

Metabolomics Market Segments Size & Growth:

Metabolomics Market is expected to increase by a $ 3.54billion by 2024 at a CAGR of 26 %. The emergence of biomarkers as a drug discovery tool and ground-breaking diagnostic will fuel the growth of metabolomics market. However, increasing the adoption rate of metabolomics as a development tool and research are expected to drive the market. The poor uptake rate of data processing, advanced technologies, and analysis by conventional workers and the lack of skilled professionals may reduce this market from growing over the 2018-20124.

Metabolomics Market Segments Share:

Metabolomics market is segmented into the technique which includes separation techniques Detection Techniques. Among these separation techniques holds the largest share due to the presence of high-performance liquid chromatography and ultra-performance liquid chromatography. Application segment includes personalised medicine, biomarker discovery, toxicology and agriculture and environmental industries. Increasing global base of geriatric population triggering the incidence rates of target diseases especially the rising prevalence of cancer and diabetes are some of the other preferable drivers of this metabolomics market.

Based on geography, North America holds the largest share in the metabolomics because of good infrastructure facilities and increase in research in the field of biofuel development and environmental analysis. Increasing demand for the improved pharmaceutical products generated by from emerging economies such as China and India is one of the most significant growth contributors of metabolomics market. Funding for research and surge in government initiatives the enhanced research and development activities across many pharmaceutical and biotechnology sectors and rising need for toxicology technologies are key drives growing the metabolomics market in Europe.

Metabolomics Market Trends:

• TimesTOF pro-Mass spectrometer was launched by the Bruker to enable a revolutionary PASEF method for the next generation proteomics.
• Scientific instruments with a new LC/Ms system that provides even high accuracy and sensitivity for an application such as food safety, environmental testing, peptide quantitation and forensic toxicology was elaborated by the Agilent technologies.
• Fortive was separated from the Danaher and launched as an independent publicly traded company.

Metabolomics Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• Bruker
• Danaher
• Agilent
• Leco
• Waters Corp.